14256-69-0

Usage

Uses

Used in Coordination Chemistry:
N1-Cyclohexyl-N1-methyl-ethane-1,2-diamine is used as a ligand in coordination chemistry for its ability to form stable complexes with metal ions, which is crucial in the development of new materials and catalysts.
Used in Pharmaceutical Synthesis:
In the pharmaceutical industry, N1-Cyclohexyl-N1-methyl-ethane-1,2-diamine is used as an intermediate in the synthesis of various drugs, contributing to the development of new therapeutic agents.
Used in Neurological Disorder Treatment:
N1-Cyclohexyl-N1-methyl-ethane-1,2-diamine is studied for its potential use in the treatment of neurological disorders, leveraging its chemical properties to target specific conditions.
Used as a Chelating Agent in Industrial Applications:
In various industrial sectors, N1-Cyclohexyl-N1-methyl-ethane-1,2-diamine is utilized as a chelating agent for metal ions, which helps in the purification processes and the removal of metal contaminants from different systems.

Upstream product

• 574-98-1 2-(2-bromoethyl)isoindoline-1,3-dione 
• 100-60-7 N-methylcyclohexylamine 
• 3638-64-0 1-nitroethylene 
• 96517-08-7 2-(cyclohexyl(methyl)amino)acetonitrile 

Downstream Products

• 91336-71-9 N-Methyl-N-cyclohexyl-N'-<2-hydroxy-aethyl>-aethylendiamin 
• 40432-71-1 <2-(Cyclohexyl-methyl-amino)-aethyl>-guanidin 

Relevant academic research and scientific papers

N-(amino)alkyl)-1-pyrrolidine, 1-piperidine and 1-homopiperidinecarboxamides (and thiocarboxamides) with sulfur linked substitution in the 2, 3 or 4-positions

Novel pyrrolidine, piperidine and homopiperidinecarboxamide and thiocarboxamide compounds having the formula: STR1 wherein X is --S--, --S(O)-- or --S(O)2 --; A is a loweralkalene chain and A1 and A2 are alkalene chains when p and d are one; R, R1 and R2 are hydrogen, loweralkyl, phenyl cycloalkyl or phenylalkyl and R1 and R2 may form a heterocyclic residue with the adjacent nitrogen atom; Q is a selected aromatic radical, and the pharmaceutically acceptable acid addition salts useful as cardiac antiarrhythmia agents are disclosed. Novel chemical intermediates, unsubstituted on pyrrolidine, piperidine and homopiperidine nitrogen but with --(A2)p --X--(A2)d --Q side chain are also disclosed.

N-[(amino)alkyl]-1-pyrrolidine, 1-piperidine and 1-homopiperidinecarboxamides (and thiocarboxamides) with sulfur linked substitution in the 2, 3 or 4-position

Novel pyrrolidine, piperidine and homopiperidinecarboxamide and thiocarboxamide compounds having the formula: STR1 wherein X is --S--, --S(O)-- or --S(O)2 --; A is a loweralkalene chain and A1 and A2 are alkalene chains when p and d are one; R, R1 and R2 are hydrogen, loweralkyl, phenyl cycloalkyl or phenylalkyl and R1 and R2 may form a heterocyclic residue with the adjacent nitrogen atom; Q is a selected aromatic radical, and the pharmaceutically acceptable acid addition salts useful as cardiac antiarrhythmia agents are disclosed. Novel chemical intermediates, unsubstituted on pyrrolidine, piperidine and homopiperidine nitrogen but with --(A2)p --X--(A2)d --Q side chain are also disclosed.